note that, due to a printer's error, two figures were mislabeled in part. In Fig. 4D Right, in the label above the images, STz should appear as ST2. In Fig. 5A , in the label above the center images, 2Kz should appear as 2KO, and in the label above the right-hand images, /3KO should appear as 2/3KO. The corrected figures and their legends appear below. Intercellular cross-talk between osteoblasts and osteoclasts is important for controlling bone remolding and maintenance. However, the precise molecular mechanism by which osteoblasts regulate osteoclastogenesis is still largely unknown. Here, we show that osteoblasts can induce Ca 2؉ oscillation-independent osteoclastogenesis. We found that bone marrow-derived monocyte/macrophage precursor cells (BMMs) lacking inositol 1,4,5-trisphosphate receptor type2 (IP3R2) did not exhibit Ca 2؉ oscillation or differentiation into multinuclear osteoclasts in response to recombinant receptor activator of NF-B ligand/macrophage colony-stimulating factor stimulation. IP3R2 knockout BMMs, however, underwent osteoclastogenesis when they were cocultured with osteoblasts or in vivo in the absence of Ca 2؉ oscillation. Furthermore, we found that Ca 2؉ oscillationindependent osteoclastogenesis was insensitive to FK506, a calcineurin inhibitor. Taken together, we conclude that both Ca 2؉ oscillation/calcineurin-dependent and -independent signaling pathways contribute to NFATc1 activation, leading to efficient osteoclastogenesis in vivo.
differentiation ͉ inositol 1,4,5-trisphosphate receptor (IP3R) ͉ osteoclast ͉ receptor activator of NF-B ligand (RANKL) ͉ calcium S keletal development requires a delicate balance between bone formation by osteoblasts and resorption by osteoclasts, and imbalances in bone remodeling cause various types of skeletal disorders (1, 2) . Excessive osteoclast differentiation and activity are the primary causes of many adult skeletal diseases. Thus, investigation of the regulatory mechanisms underlying osteoclast differentiation is crucial for understanding the physiology and pathology of the skeletal system and for developing new treatments.
Among advances in understanding molecular mechanism of osteoclast differentiation from bone marrow-derived monocyte/ macrophage precursor cells (BMMs), two factors have been shown to be indispensable for osteoclastogenesis. They are the receptor activator of NF-B ligand (RANKL), which belongs to the TNF family proteins (3) (4) (5) (6) , and macrophage colonystimulating factor (M-CSF) (7, 8) . Activation of RANK, the RANKL receptor, which is expressed on BMMs, triggers the recruitment of TNF receptor-associated factor (TRAF) family proteins, such as TRAF6 (9), followed by activation of downstream signaling molecules NF-B, JNK, Src, and c-Fos (9-13). Takayanagi et al. (14) have also demonstrated a crucial role for Ca 2ϩ oscillation/calcineurin-dependent activation of the nuclear factor of activated T cells (NFAT) transcription factor in osteoclastogenesis. They report that RANKL induces Ca 2ϩ oscillation during osteoclast differentiation, and that this oscillation is necessary for NFATc1 activation and subsequent autoamplification. NFAT activation is tightly regulated by phosphorylation, which is controlled by the Ca 2ϩ -dependent phosphatase calcineurin (15) (16) (17) . Therefore, defining the precise regulatory mechanism by which Ca 2ϩ concentrations affect calcineurin activity is necessary for understanding osteoclastogenesis.
One important factor determining intracellular Ca 2ϩ dynamics is the inositol 1,4,5-trisphosphate receptor (IP 3 R), which releases Ca 2ϩ from intracellular storage sites in the endoplasmic reticulum (ER). To date, three types of IP 3 Rs (IP 3 R1, IP 3 R2, and IP 3 R3) have been identified. All exhibit the basic properties of Ca 2ϩ channels but differ in terms of how their activity is regulated by ATP, IP 3 , Ca 2ϩ , and other proteins (18, 19) . Therefore, the subunit composition and expression levels of each IP 3 R subtype should create spatially and temporally diverse patterns of intracellular Ca 2ϩ dynamics (20, 21) . In addition, Sugawara et al. (22) reported complete abrogation of NFAT activation in DT40 cells lacking all three IP 3 R subtypes and in which no Ca 2ϩ oscillation was observed after agonist stimulation. Similarly, the contribution of IP 3 -induced Ca 2ϩ release to NFAT-dependent transcription has also been reported in cultured hippocampal neurons (23) .
Because of the importance of IP 3 Rs in intracellular Ca 2ϩ dynamics, we investigated the role of IP 3 Rs in osteoclast differentiation using mice lacking each IP 3 R subtype (24, 25) . Significantly, our analysis demonstrates the existence of a Ca 2ϩ oscillation/calcineurin-independent mechanism of osteoclastogenesis activated intercellularly by osteoblasts. Our findings indicate that intercellular communication between osteoclasts and osteoblasts through both the Ca 2ϩ oscillation/calcineurindependent and -independent signaling pathways contributes to efficient osteoclastogenesis in vivo.
Results

IP3R2 Is
Critical for RANKL/M-CSF-Induced Ca 2؉ Oscillation and Osteoclast Differentiation. To determine which IP 3 R subtype mediates osteoclast differentiation, we first examined RANKL/M-CSFinduced osteoclastogenesis using BMMs from WT mice and from mice lacking the IP 3 R subtype (24, 25) . After stimulation by recombinant RANKL plus M-CSF for 4 days, BMMs from WT mice differentiated into multinuclear osteoclasts positive for tartrate-resistant acid phosphatase (TRAP), an osteoclast marker (Fig. 1A) . Interestingly, whereas BMMs lacking IP 3 R1 or IP 3 R3 differentiated normally into TRAP-positive multinuclear cells similar to WT BMMs, RANKL/M-CSF-induced osteoclastogenesis was severely blocked in BMMs derived from IP 3 R2 or IP 3 R2/3 KO mice ( Fig. 1 A) , suggesting a critical role of IP 3 R2 in osteoclastogenesis. Consistently, immunoblotting of total proteins from RANKL/M-CSF-treated cells with antibodies specific for each IP 3 R subtype revealed that IP 3 R2 and IP 3 R3 but not IP 3 R1 (data not shown) are expressed in WT osteoclasts (Fig. 1B) . Furthermore, the overall IP 3 R expression level detected by pan-IP 3 R antibodies recognizing all three subtypes at similar levels (21) was significantly decreased in osteoclast lysates from IP 3 R2 KO mice but only modestly reduced in lysates from IP 3 R3 KO mice and was completely absent in lysates from IP 3 R2/3 KO mice (Fig. 1B Top) , indicating that IP 3 R2 is the predominant form expressed in osteoclasts.
Because sustained Ca 2ϩ oscillation induced by RANKL is reportedly necessary for osteoclastogenesis (14) , we next investigated intracellular Ca 2ϩ dynamics in IP 3 R2 KO and IP 3 R2/3 KO BMMs in response to RANKL stimulation. As reported, sustained Ca 2ϩ oscillation was clearly observed in WT cells after RANKL stimulation; however, Ca 2ϩ oscillation was abolished in BMMs from IP 3 R2 KO and IP 3 R2/3 KO mice (Fig. 1C) . These results indicate that IP 3 R2 is predominantly expressed in osteoclasts and is critical to generate recombinant RANKL/M-CSFinduced Ca 2ϩ oscillation and subsequent osteoclastogenesis. (Fig. 1 A) . Indeed, when we ectopically expressed a constitutively active form of NFATc1 (caNFATc1) in IP 3 R2/3 KO BMMs using retroviral gene transfer, infected IP 3 R2/3 KO BMMs differentiated into TRAP-positive multinuclear osteoclasts similar to WT BMMs after RANKL/M-CSF stimulation (Fig. 2C) . IP 3 R2/3 KO osteoclasts overexpressing caNFATc1 were mature and functional, because they resorbed bone surface ( Fig. 2D ) and expressed terminal osteoclast markers (Fig. 2E ). In contrast, although the expression levels of c-Fos in IP 3 R2 KO or IP 3 R2/3 KO cells were slightly decreased compared with WT osteoclasts (Fig. 2 A) , we could not rescue recombinant RANKLinduced osteoclastogenesis of IP 3 R2/3 KO cells by overexpressing c-Fos (data not shown). These results indicate that impaired NFATc1 activation is the primary cause of defects in osteoclastogenesis seen in IP 3 R2 KO and IP 3 R2/3 KO BMMs.
RANKL/M-CSF-Induced NFATc1 Activation Is Abolished in BMMs Lack
Osteoblasts Induce Osteoclastogenesis of BMMs Lacking IP3R2 in a
Ca 2؉ Oscillation/Calcineurin-Independent Manner. Because osteoblasts regulate the differentiation and function of osteoclasts by producing M-CSF, RANKL, and other cytokines (1) and membrane-bound molecules in vivo (26), we examined osteoclastogenesis induced by coculture with osteoblasts. Interestingly, we found that IP 3 R2/3 KO BMMs underwent osteoclast differentiation when cocultured with primary calvarial osteoblasts (Fig.  3A) or ST2 cells (Fig. 4B Upper) , although the numbers of multinuclear osteoclasts were almost half of those seen in WT controls. Interestingly, we did not detect Ca 2ϩ oscillations in multinuclear IP 3 R2/3 KO osteoclasts generated by coculture with primary osteoblasts (Fig. 3B) . Therefore, although IP 3 R2-mediated Ca 2ϩ oscillation is required for efficient osteoclastogenesis, these results suggest that osteoblasts rescue deficiencies in osteoclastogenesis in IP 3 R2 KO BMMs through Ca 2ϩ oscillation/calcineurin-independent mechanism(s).
To confirm the existence of Ca 2ϩ oscillation/calcineurinindependent signaling for osteoclastogenesis in a coculture system, we investigated the effect of FK506, a specific calcineurin inhibitor, on osteoblast-induced osteoclastogenesis. As reported (14) , FK506 abolished multinuclear osteoclasts and nuclear NFATc1 localization during the course of recombinant RANKL/M-CSF-induced osteoclast differentiation from WT BMMs at 1.0 M (Fig. 4A) abolish WT osteoclast differentiation (Fig. 4B ). This suggests that both Ca 2ϩ oscillation/calcineurin-dependent and -independent signal transduction pathways are activated during osteoblast-induced osteoclastogenesis, and that residual osteoclastogenesis seen in the presence of FK506 is induced by the Ca 2ϩ oscillation/calcineurin-independent pathway. Consistently, FK506 treatment did not significantly affect osteoclastogenesis by IP 3 R2/3 KO BMMs in a coculture system that relies on Ca 2ϩ oscillation-independent osteoclastogenesis (Fig. 4B) . We also examined the expression level and cellular localization of NFATc1 in FK506-treated multinuclear osteoclasts. In recombinant RANKL/M-CSF-induced osteoclastogenesis, FK506 application severely decreased NFATc1 expression and reduced the mobility of NFATc1 on SDS/PAGE at 100 kDa in WT cells (Fig. 4C, lanes 1 and 2) . IP 3 R2/3 KO cells did not show strong NFATc1 expression, and only a faint band migrating at 100 kDa was observed in recombinant RANKL/M-CSF-treated cells (Fig. 4C, lane 3) . By contrast, under coculture conditions, FK506 treatment slightly reduced NFATc1 mobility but did not apparently affect its expression level in cocultured WT cells in which both Ca 2ϩ oscillation-dependent and -independent NFATc1 activation were functioning (Fig. 4C, lanes 5 and 6) . In addition, a clear NFATc1 band smaller than 100 kDa was detected in cocultured IP 3 R2/3 KO cells. Interestingly, NFATc1 mobility on SDS/PAGE in FK506-treated cocultured WT cells was almost the same as that in nontreated cocultured IP 3 R2/3 KO cells (Fig. 4C, lanes 6 and 7) . Furthermore, the expression and mobility of NFATc1 in IP 3 R2/3 KO cells in coculture were not affected by FK506 treatment (Fig. 4C, lanes 7 and 8) . Immunocytochemical studies revealed strong nuclear NFATc1 signals in both WT and IP 3 R2/3 KO multinuclear osteoclasts, even in the presence of FK506 (Fig. 4D) . Taken together, these results suggest that a Ca 2ϩ oscillation/calcineurin-independent NFATc1 activation mechanism is activated upon osteoblastinduced osteoclastogenesis, and that some modification, such as the phosphorylation, of NFATc1 activated by the Ca 2ϩ oscillation-independent signal pathway during osteoblast-induced osteoclastogenesis, clearly differs from that seen during RANKL/ MCSF-induced osteoclastogenesis.
Ca 2؉ Oscillation-Independent Osteoclastogenesis Occurs in Vivo. Finally, we analyzed bone phenotypes of IP 3 R2-deficient mice to confirm that Ca 2ϩ oscillation/calcineurin-independent osteoclastogenesis occurs in vivo. Consistent with results seen in the coculture system described above, IP 3 R2 KO and IP 3 R2/3 KO mice showed TRAP-positive multinuclear osteoclasts in femurs (Fig. 5A) , and osteoclast numbers and bone volume seen in IP 3 R2/3 KO mice at P17 did not differ significantly from those seen in WT mice (Fig. 5B) . Even at the adult stage, the bone density of IP 3 R2 KO is not increased compared with WT mice [supporting information (SI) Fig. S1 A] , and IP 3 R2/3 KO mice rather showed decreased bone density probably due to the malnutrition caused by indigestion and the resulting decreased of body weight (ref. 25 and Fig. S1B ). These results strongly support the idea that osteoblasts promote osteoclastogenesis through NFATc1 activation in both a Ca 2ϩ oscillation/calcineurindependent and -independent manner (Fig. 5C ).
Discussion
Although it is well known that Ca 2ϩ oscillation frequency is important for NFAT activation (27) and RANKL-induced osteoclastogenesis (14, 28) , how Ca 2ϩ oscillation is established during osteoclastogenesis remains unknown. In this study, using BMMs from mice lacking various IP 3 Rs, we showed that IP 3 R2 critically determines generation of Ca 2ϩ oscillation and subsequent NFATc1 activation in RANKL/M-CSF-induced osteoclastogenesis. By contrast, although we found that IP 3 R3 is expressed in osteoclasts, we did not observe changes in RANKLinduced Ca 2ϩ oscillation (data not shown) or osteoclastogenesis in IP 3 R3 KO BMMs (Fig. 1 A) . These results may be due to the predominant expression of IP 3 R2 among the three IP 3 R subtypes in BMMs (Fig. 1B) and may reflect previous findings that IP 3 R2, rather than IP 3 R3, contributes to the establishment of sustained Ca 2ϩ oscillation (20, 21) . However, because we detected faint nuclear NFATc1 immunosignaling in a small population of IP 3 R2 KO BMMs after RANKL stimulation (Fig. 2B) , IP 3 R3 may contribute in part to NFATc1 activation via a transient Ca 2ϩ increase not detected under our experimental conditions. It should be noted that IP 3 R2/3 KO BMMs showed lower basal levels of intracellular Ca 2ϩ than did WT BMMs (Figs. 1C and 3B) . Depletion of extracellular Ca 2ϩ from WT BMMs reduced not only Ca 2ϩ oscillation but also basal Ca 2ϩ levels to those observed in BMMs lacking IP 3 R2/3 (Fig. S2) . This observation suggests that IP 3 Rs are necessary for Ca 2ϩ influx and to maintain Ca 2ϩ oscillation over the relatively high cytosolic basal Ca 2ϩ level.
An important finding reported here is the observation of Ca 2ϩ oscillation/calcineurin-independent osteoclastogenesis. It is clear that IP 3 R deficiency impairs osteoclast differentiation, because RANKL-induced Ca 2ϩ oscillation is essential for osteoclastogenesis. However, we show that IP 3 R2 KO and IP 3 R2/3 KO mice exhibit TRAP-positive multinuclear osteoclasts in femurs, and that osteoblasts can induce IP 3 R2/3 KO osteoclastogenesis without detectable Ca 2ϩ oscillation in osteoclasts. We also demonstrate that FK506 treatment of WT cells decreases the number of osteoblast-induced multinuclear osteoclasts only by half and does not affect IP 3 R2/3 KO cells, which lack the Ca 2ϩ oscillation/calcineurin-dependent pathway for osteoclast differentiation (Fig. 4B) . Because the mobility of NFATc1 in WT osteoclasts cocultured with osteoblasts was reduced by 1.0 M FK506 (Fig. 4C Right, lanes 5 and 6), 1.0 M FK506 likely inhibited Ca 2ϩ /calcineurin-mediated NFATc1 dephosphorylation even in the coculture system. These results support our hypothesis that osteoblasts can induce Ca 2ϩ oscillation/ calcineurin-independent osteoclastogenesis.
An intense nuclear NFATc1 signal was observed in IP 3 R2/3 KO osteoclasts during osteoblast-induced Ca 2ϩ oscillation/ calcineurin-independent osteoclastogenesis. It is not known how NFATc1 is activated intercellularly by osteoblasts in a Ca 2ϩ oscillation/calcineurin-independent manner. It is known that NFATc1 activity and translocation are controlled by its phosphorylation status, which in turn is regulated by phosphatases and serine/threonine kinases such as GSK3␤, PKA, casein kinase I, and DYRK1 (29) (30) (31) . We observed a subtle mobility shift of NFATc1 on SDS/PAGE between recombinant RANKL/M-CSF-induced and osteoblast-induced osteoclastogenesis: NFATc1 from osteoclasts cocultured with ST2 cells migrated more slowly than NFATc1 in RANKL/M-CSF-treated cells but faster than highly phosphorylated NFATc1 in FK506-treated cells (Fig. 4C, lanes 1, 2, and 5) . Thus, we are currently analyzing the difference between recombinant RANKL/M-CSF-induced osteoclastogenesis and osteoblast-induced osteoclastogenesis in terms of NFATc1 phosphorylation status.
In summary, the findings presented here further our understanding of the molecular mechanisms underlying osteoclast differentiation. We show that IP 3 R2 is necessary for RANKLinduced Ca 2ϩ oscillation and efficient NFATc1 activation. We also find that NFATc1 is activated by both Ca 2ϩ oscillation/ calcineurin-dependent and -independent signal pathways in vivo, and that the Ca 2ϩ oscillation-independent pathway depends completely on osteoblasts and is not activated during RANKL/ M-CSF-induced osteoclastogenesis. It is known that treatment with immunosuppressants leads to bone loss (32) . Our findings of immunosuppressant-resistant osteoclastogenesis in vivo would partially explain this phenomenon, as well as defects in osteoblast function (33) . Further analysis of Ca 2ϩ oscillationindependent osteoclastogenesis should reveal the precise molecular mechanisms of osteoclastogenesis in vivo, leading to development of new therapies for skeletal disease.
Materials and Methods
Mice and Bone Analysis. Generation of IP3R1 KO, IP3R2 KO, IP3R3 KO, and IP3R2/3 KO mice has been described (24, 25) . Histological experiments were performed as described (14) . Animals were ethically treated according to the instructions for animal care and use of the Institute of Medical Science, University of Tokyo, and RIKEN Brain Science Institute.
In Vitro Osteoclastogenesis. Nonadherent bone marrow cells derived from mice were seeded (2 ϫ 10 5 cells per well in a 24-well plate) and cultured in a ␣-MEM (GIBCO-BRL) with 10% FBS (JRH Biosciences) containing 10 ng/ml M-CSF (R&D Systems). After 3 days, adherent cells were used as BMMs. These osteoclast progenitor cells were further cultured in the presence of 100 ng/ml soluble RANKL (PeproTech) and 10 ng/ml M-CSF to generate osteoclasts. Reagents were used at these concentration unless otherwise indicated. To analyze the effect of FK506 (Calbiochem and Fujisawa Pharmaceutical) on osteoclastogenesis, FK506 was added at the same time as RANKL. Four days later, TRAP-positive multinuclear cells (more than three nuclei) were counted. ST2 cells were described in ref. 34 . For coculture with primary osteoblasts or ST2 cells, BMMs were seeded at 6 ϫ 10 5 cells per cm 2 with 6 ϫ 10 4 /cm 2 ST2 cells and cultured with 10 Ϫ8 M 1, 25-dihydroxyvitamin D3 for 4 -5 days. In the case of coculture with primary osteoblasts for Ca 2ϩ imaging, bone marrow cells were cultured in ␣-MEM with 10% FBS containing 50 g/ml L-ascorbic acid (Sigma), 10 mM ␤-glycerophosphate, 10 ng/ml M-CSF, and 100 ng/ml soluble RANKL for 6 days.
Immunoblotting. Differentiated osteoclasts were washed with PBS, lysed with sample buffer (125 mM Tris⅐HCl, pH 6.8; 20% glycerol; 4.0% SDS; 10% 2-mercaptoethanol; 0.1% bromophenol blue) and boiled 3 min. Primary antibodies used were anti-IP3R1 mAb 18A10 (35), anti-IP3R2 mAb KM1083, anti-IP3R3 mAb KM1082 (36), anti-pan-IP3R polyclonal antibody (21), antiNFATc1 mAb 7A6 (Santa Cruz Biotechnology), anti-TRAF6 polyclonal antibody (H-274, Santa Cruz Biotechnology), anti-c-Fos polyclonal antibody (Santa Cruz Biotechnology), and anti-␤-actin mAb AC-15 (Sigma).
Immunocytochemistry. BMMs grown on glass coverslips were stimulated with RANKL/M-CSF for the indicated periods, washed once with PBS, fixed in 4.0% paraformaldehyde/PBS for 10 min, and treated with 0.2% Triton X-100/PBS for 5 min. Cells were sequentially incubated with 1.0% skim milk/PBS for 1 h and 1.0 g/ml anti-NFATc1 mAb 7A6 (Santa Cruz Biotechnology) for 1 h at room temperature (RT). After washing with PBS, cells were stained with Alexa Fluor 488-conjugated goat anti-mouse IgG or Alexa Fluor 594-conjugated goat anti-mouse IgG (Molecular Probes) for 1 h at RT. After washing, coverslips were mounted with Vectashield (Vector Laboratories) and observed under a IX-70 confocal fluorescence microscope (Olympus).
Intracellular Ca 2؉ Imaging. Cells plated on 3.5-cm poly-L-lysine-coated glass bottom dishes (Matsunami) were loaded with 5 M Fura-2/AM (Dojindo) for 30 min at RT in loading solution: 115 mM NaCl, 5.4 mM KCl, 1 mM MgCl2, 2 mM CaCl2, 20 mM Hepes, and 10 mM glucose, pH 7.42. Fura-2 fluorescent images were analyzed using an inverted microscope (ECLIPSE TE300, Nikon) and a video image analysis system (Argus-50/CA, Hamamatsu Photonics) with excitation filters at 340 Ϯ 10 and 380 Ϯ 10 nm, a dichroic beam splitter at 400 nm, and a bandpass emission filter at 510 -550 nm. The recording solution contained: 115 mM NaCl, 5.4 mM KCl, 1 mM MgCl2, 2 mM CaCl2, 20 mM Hepes, and 10 mM glucose, pH 7.42.
Bone Resorption Assay. Infected cells were cultured on bone slices prepared as described (26) for 7 days in the presence of RANKL/M-CSF. Bone slice surfaces were visualized by backscattered electron imaging, as described (37) .
Real-Time RT-PCR. Total RNA was extracted from osteoclasts infected with virus expressing GFP or GFP ϩ caNFATc1. First-strand cDNA was produced from total RNA using Reverse Transcriptase SuperScript II (Invitrogen) and oligonucleotide (dT) primers. Calcitonin receptor (Calcr) and Cathepsin K (Ctsk) transcripts were quantified on an ABI PRISM 7000 (Applied Biosystems) using SYBR green and Integrin ␤3 (Itgb3, Assay ID, Mm00443980m1), and Gapdh transcripts were quantified using primer/probe kit (TaqMan Gene Expression Assays, Applied Biosystems). Calcr, Ctsk, and Intgb3 transcripts were normalized to glyceraldehyde-3-phosphate dehydrogenase (Gapdh) transcripts. Primer sequences were: Calcr-1376F, 5Ј-TTACCGACGAGCAACGCCTA-3Ј; Calcr-1584R, 5Ј-CACGCGGACAATGTTGAGAA-3Ј; Ctsk-F, 5Ј-ACGGGACTCAGAATAC-CTCCCT-3Ј; and Ctsk-R, 5Ј-CTCTCTGTACCCTCTGCATTTAGC-3.
Statistical Analysis. Statistical analysis was performed by using Student's t test ( * , P Ͻ 0.05; ** , P Ͻ 0.01). All data are presented as means Ϯ SD.
For the analysis of bone density, see SI Materials and Methods.
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